Home › Funds › Capital International Investors › VRTX

Capital International Investors position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Capital International Investors reported holding 5,059,186 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.65B, representing 0.55% of its reported portfolio and ranking #46 among its reported holdings. Capital International Investors has disclosed VRTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)5.06M sh
Reported value held$2.65B
Portfolio Weight0.55%
First reportedQ4 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capital International Investors's VRTX position evolved

Capital International Investors first disclosed a stake in VRTX in Q4 2024 at 342,512 shares (US$137.9M). The position peaked in Q3 2026 at 5,059,186 shares, worth US$2.65B. Across 8 filings, Capital International Investors increased the stake 6 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,059,186 shares valued at US$2.65B — an increase of 364,042 shares quarter over quarter.. Notable position changes include a 90% increase in Q1 2025 (shares fell 8% over the following quarter), a 306% increase in Q2 2025 (shares fell 12% over the following quarter), a 78% increase in Q3 2025 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 342.51K $137.93M New
Q1 2025 649.90K $315.08M Add
Q2 2025 2.64M $1.17B Add
Q3 2025 4.69M $1.84B Add
Q4 2025 4.73M $2.15B Add
Q1 2026 5.13M $2.29B Add
Q2 2026 4.70M $2.33B Reduce
Q3 2026 5.06M $2.65B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 31 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Capital International Investors held VRTX?

Capital International Investors has disclosed VRTX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Capital International Investors's current position in VRTX?

As of Q3 2026, Capital International Investors holds 5.06M shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $2.65B, representing 0.55% of its reported portfolio and ranking #46.

Has Capital International Investors been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Capital International Investors increased its position in VRTX. The position peaked in Q3 2026 at 5.06M shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.